Finance

Lists
0950:HKG
Lee's Pharmaceutical Holdings Ltd
HK$1,08
+1,41%
(+0,015) 1D
16 Okt., 11:58:29 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 0950...
Open
HK$1,09
High
HK$1,09
Low
HK$1,05
Mkt. cap
633,03 m
Avg. vol.
397,40 k
Volume
389,50 k
Dividend
5,37%
Quarterly dividend
HK$0,01
Ex-dividend date
25 Sep. 2026
P/E ratio
5,31
52-wk high
HK$2,10
52-wk low
HK$0,99
EPS
HK$0,20
Shares outstanding
592,03 m
No. of employees
1 k
Open
HK$1,09
High
HK$1,09
Low
HK$1,05
Mkt. cap
633,03 m
Avg. vol.
397,40 k
Volume
389,50 k
Dividend
5,37%
Quarterly dividend
HK$0,01
Ex-dividend date
25 Sep. 2026
P/E ratio
5,31
52-wk high
HK$2,10
52-wk low
HK$0,99
EPS
HK$0,20
Shares outstanding
592,03 m
No. of employees
1 k
News stories
From web sources and news partners
About Lee's Pharmaceutical Holdings Ltd
CEO-
Employees1,14 k
Founded1994
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in HKD
Loading Previous Earnings...
Revenue
Net income
All values in HKD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
370,58 m
370,58 m
398,28 m
398,28 m
Cost of goods sold
185,83 m
185,83 m
174,56 m
174,56 m
Cost of revenue
185,83 m
185,83 m
174,56 m
174,56 m
Research and development expenses
34,67 m
34,67 m
76,29 m
76,29 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
151,39 m
151,39 m
183,30 m
183,30 m
Operating expense
162,80 m
162,80 m
181,34 m
181,34 m
Total operating expenses
348,63 m
348,63 m
355,90 m
355,90 m
Operating income
21,95 m
21,95 m
42,38 m
42,38 m
Other non operating income
-71,00 k
-71,00 k
-216,50 k
-216,50 k
EBT including unusual items
6,11 m
6,11 m
43,23 m
43,23 m
EBT excluding unusual items
14,29 m
14,29 m
43,23 m
43,23 m
Income tax expense
6,07 m
6,07 m
11,80 m
11,80 m
Effective tax rate
99,43%
99,43%
27,29%
27,29%
Other operating expenses
-23,11 m
-23,11 m
-78,90 m
-78,90 m
Net income
12,38 m
12,38 m
47,51 m
47,51 m
Net profit margin
3,34%
3,34%
11,93%
11,93%
Earnings per share
-
-
-
-
Interest and investment income
367,00 k
367,00 k
4,42 m
4,42 m
Interest expense
-2,37 m
-2,37 m
-2,66 m
-2,66 m
Net interest expenses
-2,00 m
-2,00 m
1,76 m
1,76 m
Depreciation and amortization charges
-
-
-
-
EBITDA
29,76 m
29,76 m
90,70 m
90,70 m
Gain or loss from assets sale
99,00 k
99,00 k
-
-
AI content may include mistakes. Learn more
Google-programme